Dr. Yale Sacks, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2200 Old Military Rd, Central Point, OR 97502 Phone: 541-772-1559 |
News Archive
PET and SPECT are key molecular imaging technologies for Bruker's Preclinical Imaging division, allowing Bruker to offer the highest-performance SiPM-PET/SPECT/CT and integrated SiPM-PET/MR imaging systems.
DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced revenue of $396,468 and a net loss of $4,034,364 or $0.09 per share for the third quarter ending July 31, 2009.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced its Central Coding™ application has become the first product to achieve certification by the Uppsala Monitoring Center (UMC). Launched today ("Uppsala Monitoring Centre Launches Software Certification Program for WHO Drug Dictionary Enhanced"), UMC's new certification is designed to help software developers quickly and easily integrate the WHO Drug Dictionary Enhanced.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.
› Verified 2 days ago